NT—proBNP对左室收缩及舒张功能障碍的预测价值(3)
 |
| 第1页 |
参见附件。
[5] Schiller NB，Shah PM，Crawford M，et al. Recommendations for quantitation of the leftventricle by two—dimensional echocardiography.American Society of Echocardiography Committee on Standards，Subcommittee on Quantitation of Two— Dimensional Echocardiograms[J]. J Am Soc Echocardiogr，1989，2(5)：358—367.
[6] Hartmann F，Packer M，Coats AJ，et al. Prognostic impact of plasma N—：enninal pro—brain natriuretic peptide in severe chronic congestive heart failure：a substudy of the Carvedilol Prospective Ran—doaii/ed Cumulative Survival COPERNICUS) trial[J]. Circulation，2004，110：1780—1786.
[7] Weber T，Auer J，Eber B. The diagnostic and prognostic value of brain natriuieiic peptidc and aminoterminal (nt)—pro brain natri—uretie peptide[J]. Curr Pharm De，2005，11(4)：511—525.
[8] Masson S，Vago T，Baldi G，et al. Comparative measurement of Nterminal pro—brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with hear failure[J]. Clin Chem Lab Med，2002，40：761—763.
[9] Pfister R，Scholz M，Wielcknes K，et al. Use of NT—proBNP in routine testing and comparison to BNP[J]. Eur J Heart Fail，2004，6：289—293.
[10] Seino Y，Ogawa A，Yamashita T，et al. Application of NT—proBNP and BNP measurements in cardiac care： a more discerning marker for the detection and evaluation of heart failure[J]. Eur J Heart Fail ......
您现在查看是摘要介绍页，详见PDF附件(2904kb)。